Diadem is an innovative blood-based test exploiting a proprietary antibody targeting a specific conformation of p53 protein.
Diadem is an innovative blood-based test exploiting a proprietary antibody targeting a specific conformation of p53 protein.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 7, 2022 | Debt Financing | €7.50M | 1 | European Investment Bank | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
European Investment Bank | Yes | Debt Financing |